Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Verona Pharma Plc
Pharmaceutical Preparations United Kingdom
Company Description
Verona Pharma Plc researches and develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases. It engages in discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis, chronic obstructive pulmonary disease and cough. The company has three potential drug treatments: RPL554 is an innovative dual phosphodiesterase 3/4 inhibitor with both bronchodilator and anti-inflammatory properties. VRP700 is an innovative product for suppressing chronic severe cough in patients with underlying lung disease. With its third programme, the company is investigating novel anti-inflammatory molecules, called NAIPs, for a wide range of respiratory and inflammatory diseases. Verona Pharma was founded by Michael J. A. Walker in April 2004 and is headquartered in London, the United Kingdom.
Similar to: Columbia Laboratories, Inc., BioGaia AB, GW Pharmaceuticals Plc
Featured Company
Fidelity Asian Values Plc
Tadworth, SU, GB
Fidelity Asian Values Plc is a Closed-End Investment Fund/Investment. The company invests in information technology, energy, financial… Learn more →
You may also be interested in:
GW Pharmaceuticals Plc
Salisbury, WI, GB
GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →
BioGaia AB
Stockholm, SE
BioGaia develops, markets and sells probiotic products with documented health benefits. Its products are primarily based on different… Learn more →
Columbia Laboratories, Inc.
Livingston, NJ, US
Columbia Laboratories, Inc. develops, manufactures and sells pharmaceutical products. Its pharmaceutical products include CRINONE… Learn more →